Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W9RR
|
|||
| Former ID |
DIB021131
|
|||
| Drug Name |
UNC1215
|
|||
| Synonyms |
UNC1215; 1415800-43-9; UNC-1215; UNC 1215; (2-(phenylamino)-1,4-phenylene)bis((4-(pyrrolidin-1-yl)piperidin-1-yl)methanone); CHEMBL2426364; 2-Phenylamino-1,4-bis(4-(pyrrolidinyl)piperidinyl)benzamide; [2-(Phenylamino)benzene-1,4-Diyl]bis{[4-(Pyrrolidin-1-Yl)piperidin-1-Yl]methanone}; MLS006011024; GTPL8232; SCHEMBL19730381; CHEBI:95086; EX-A193; AOB4333; MolPort-028-720-812; HMS3652P22; KS-00000T6B; BCP07393; ZINC83253967; s7088; BDBM50440614; 2782AH; AKOS024458279; SB19337; CS-1646; NCGC00344623-12; NCGC00344623-02; SMR004702819
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C32H43N5O2
|
|||
| Canonical SMILES |
C1CCN(C1)C2CCN(CC2)C(=O)C3=CC(=C(C=C3)C(=O)N4CCC(CC4)N5CCCC5)NC6=CC=CC=C6
|
|||
| InChI |
1S/C32H43N5O2/c38-31(36-20-12-27(13-21-36)34-16-4-5-17-34)25-10-11-29(30(24-25)33-26-8-2-1-3-9-26)32(39)37-22-14-28(15-23-37)35-18-6-7-19-35/h1-3,8-11,24,27-28,33H,4-7,12-23H2
|
|||
| InChIKey |
PQOOIERVZAXHBP-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1415800-43-9
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| ChEBI ID |
CHEBI:95086
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Lethal(3)malignant brain tumor-like 3 (L3MBTL3) | Target Info | Agonist | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain. Nat Chem Biol. 2013 Mar;9(3):184-91. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.